|
MAGED4B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.781000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.226000E-02 |
| Normal-vs-Stage2 |
6.047200E-01 |
| Normal-vs-Stage3 |
3.170200E-01 |
| Normal-vs-Stage4 |
9.402200E-02 |
| Stage1-vs-Stage2 |
7.069800E-01 |
| Stage1-vs-Stage3 |
2.120600E-01 |
| Stage1-vs-Stage4 |
1.582380E-02 |
| Stage2-vs-Stage3 |
2.677200E-01 |
| Stage2-vs-Stage4 |
9.735500E-02 |
| Stage3-vs-Stage4 |
6.594400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.632200E-01 |
| Normal-vs-AfricanAmerican |
4.821800E-01 |
| Normal-vs-Asian |
1.999180E-01 |
| Caucasian-vs-AfricanAmerican |
9.201000E-01 |
| Caucasian-vs-Asian |
2.595600E-01 |
| AfricanAmerican-vs-Asian |
1.397610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.655000E-01 |
| Normal-vs-Female |
9.532200E-01 |
| Male-vs-Female |
5.074000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.032000E-02 |
| Normal-vs-Age(41-60Yrs) |
5.260800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.004000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.825700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.262800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.832100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.420400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.110400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.820180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.174580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.601600E-01 |
| Normal-vs-Grade 2 |
1.314370E-02 |
| Normal-vs-Grade 3 |
4.310000E-01 |
| Normal-vs-Grade 4 |
4.396300E-02 |
| Grade 1-vs-Grade 2 |
8.709800E-01 |
| Grade 1-vs-Grade 3 |
3.226400E-01 |
| Grade 1-vs-Grade 4 |
5.815500E-02 |
| Grade 2-vs-Grade 3 |
2.242000E-01 |
| Grade 2-vs-Grade 4 |
7.577300E-03 |
| Grade 3-vs-Grade 4 |
6.813800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.11355369369903E-13 |
| Normal-vs-ccB subtype |
1.013560E-01 |
| ccA subtype-vs-ccB subtype |
1.080420E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.891000E-01 |
| Normal-vs-N1 |
1.174160E-01 |
| N0-vs-N1 |
5.055800E-01 |
|
|
